Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2023 ∙ Fasce, A. Schmid, P. Holford, D. L. Bates, L. Gurevych, I. Lewandowsky, S.
A taxonomy of anti-vaccination arguments from a systematic literature review and text modelling
All age groups Acceptance
Rating:
Not applicable
2023 ∙ Kumar, G. Jena, S. Snigdha, N. T. Basha, S. Narayanan, J. K. Luke, A. M.
Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis
South-East Asia India All age groups Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Derbie, A. Mekonnen, D. Misgan, E. Maier, M. Woldeamanuel, Y. Abebe, T.
Acceptance of human papillomavirus vaccination and parents’ willingness to vaccinate their adolescents in Ethiopia: a systematic review and meta-analysis
Africa Ethiopia Parents/caregivers Human papillomavirus (HPV) Acceptance Coverage
Rating:
Not applicable
2023 ∙ Doggen, Kris van Hoek, Albert Jan Luyten, Jeroen
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
Newborn Children Adolescents Adults Pneumococcal disease Rotavirus Human papillomavirus (HPV) Meningococcal disease Mumps Measles Rubella Economic aspects
Rating:
Not applicable
2023 ∙ Dadari, I. Belt, R. V. Iyengar, A. Ray, A. Hossain, I. Ali, D. Danielsson, N. Sodha, S. V.
Achieving the IA2030 Coverage and Equity Goals through a Renewed Focus on Urban Immunization
Newborn Children Adolescents Coverage Ethical issues
Rating:
Not applicable
2023 ∙ Amisha, F. Saluja, P. Malik, P. Van Rhee, F.
Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: A systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Nabizadeh, F. Noori, M. Rahmani, S. Hosseini, H.
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Pichichero, Michael Malley, Richard Kaur, Ravinder Zagursky, Robert Anderson, Porter
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
Children Adolescents Pneumococcal disease Efficacy/effectiveness Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Liatsou, E. Ntanasis-Stathopoulos, I. Lykos, S. Ntanasis-Stathopoulos, A. Gavriatopoulou, M. Psaltopoulou, T. Sergentanis, T. N. Terpos, E.
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Putri, E. A. C. Munir, M. Setiawan, H. K. Herawati, L. Sari, G. M. Wungu, C. D. K. Susilo, H. Sutanto, H.
Adverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
Loading...